A systematic review of taxane-containing regimens for metastatic breast cancer

por Ghersi, D, Wilcken, N, Simes, R J
Publicado 2005

Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer

por Lee, C K, Stockler, M R, Coates, A S, Gebski, V, Lord, S J, Simes, R J
Publicado 2010

Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer

por Stockler, M R, Tattersall, M H N, Boyer, M J, Clarke, S J, Beale, P J, Simes, R J
Publicado 2006

Common genetic variants do not predict recurrent events in coronary heart disease patients

por Thompson, P. L., Hui, J., Beilby, J., Palmer, L. J., Watts, G. F., West, M. J., Kirby, A., Marschner, S., Simes, R. J., Sullivan, D. R., White, H. D., Stewart, R., Tonkin, A. M.
Publicado 2022

Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

por Lee, C K, Gurney, H, Brown, C, Sorio, R, Donadello, N, Tulunay, G, Meier, W, Bacon, M, Maenpaa, J, Petru, E, Reed, N, Gebski, V, Pujade-Lauraine, E, Lord, S, Simes, R J, Friedlander, M
Publicado 2011

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

por Lee, C K, Simes, R J, Brown, C, Lord, S, Wagner, U, Plante, M, Vergote, I, Pisano, C, Parma, G, Burges, A, Bourgeois, H, Högberg, T, Bentley, J, Angleitner-Boubenizek, L, Ferrero, A, Richter, B, Hirte, H, Gebski, V, Pfisterer, J, Pujade-Lauraine, E, Friedlander, M
Publicado 2011

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

por Jonker, D J, Karapetis, C S, Harbison, C, O'Callaghan, C J, Tu, D, Simes, R J, Malone, D P, Langer, C, Tebbutt, N, Price, T J, Shapiro, J, Siu, L L, Wong, R P W, Bjarnason, G, Moore, M J, Zalcberg, J R, Khambata-Ford, S
Publicado 2014